Welcome to Dwaey, specifically on Risedronate Sodium + Calcium page.
This medicine contains important and useful components, as it consists of
Risedronate Sodium + Calcium is available in the market in concentration.
Risedronate Sodium + Calcium
- Administration Timing: Risedronate should be taken on an empty stomach with a full glass of water, at least 30 minutes before the first food, drink, or medication of the day. Calcium supplements should be taken at a different time, as calcium can interfere with risedronate absorption.
- Posture After Dose: Remain upright (sitting or standing) for at least 30 minutes after taking risedronate to reduce the risk of esophageal irritation.
- Calcium Intake: Ensure adequate dietary calcium and vitamin D intake, but avoid taking calcium supplements within 2 hours of risedronate.
- Renal Impairment: Use with caution in patients with renal impairment, as risedronate is excreted by the kidneys. Avoid in severe renal impairment (CrCl <30 mL/min).
- Gastrointestinal Issues: Discontinue use if severe esophageal or gastrointestinal symptoms (e.g., difficulty swallowing, pain, or heartburn) occur.
- Dental Health: Inform your dentist about risedronate use, as it may increase the risk of osteonecrosis of the jaw, especially after dental procedures.
- Pregnancy and Lactation: Not recommended for use during pregnancy or breastfeeding unless absolutely necessary.
- Osteoporosis: Risedronate is used to treat and prevent osteoporosis in postmenopausal women and men. Calcium is essential for maintaining bone density.
- Glucocorticoid-Induced Osteoporosis: Prevents bone loss in patients taking long-term corticosteroids.
- Paget’s Disease: Treats Paget’s disease of bone, a condition characterized by abnormal bone remodeling.
- Bone Health Maintenance: Calcium supports overall bone health and works synergistically with risedronate to strengthen bones.
- Fracture Prevention: Reduces the risk of vertebral and non-vertebral fractures in high-risk patients.
- Hypocalcemia Prevention: Calcium supplementation ensures adequate calcium levels, which is critical for risedronate’s effectiveness.
- Hypocalcemia: Do not use risedronate in patients with low calcium levels until hypocalcemia is corrected.
- Esophageal Abnormalities: Avoid in patients with esophageal disorders that delay emptying, such as strictures or achalasia.
- Severe Renal Impairment: Contraindicated in patients with a creatinine clearance (CrCl) of less than 30 mL/min.
- Allergy: Do not use in patients with known hypersensitivity to risedronate, calcium, or any component of the formulation.
- Pregnancy: Avoid during pregnancy unless the benefits outweigh the risks.
- Inability to Sit Upright: Contraindicated in patients who cannot remain upright for at least 30 minutes after taking the medication.
- Gastrointestinal Issues: Common side effects include nausea, abdominal pain, diarrhea, and heartburn.
- Esophageal Irritation: Rarely, risedronate can cause esophagitis or esophageal ulcers.
- Musculoskeletal Pain: Some patients may experience bone, joint, or muscle pain.
- Hypocalcemia: Low calcium levels can occur, especially if calcium intake is inadequate.
- Headache and Dizziness: Mild headaches or dizziness may occur.
- Allergic Reactions: Rarely, rash, itching, or swelling may occur.
- Osteonecrosis of the Jaw: A rare but serious side effect, particularly after dental procedures.
- Risedronate: A bisphosphonate that inhibits osteoclast-mediated bone resorption, leading to increased bone mass and strength.
- Calcium: Essential for bone mineralization and maintaining bone density. Works synergistically with risedronate to improve bone health.
- Bone Remodeling: Risedronate reduces bone turnover, while calcium provides the raw material for bone formation.
- Antiresorptive Effect: Risedronate binds to hydroxyapatite in bone, preventing the breakdown of bone tissue.
- Calcium Absorption: Vitamin D enhances calcium absorption, ensuring adequate calcium levels for bone health.
- Fracture Prevention: The combination reduces the risk of fractures by improving bone density and strength.
- Calcium Supplements: Calcium can significantly reduce the absorption of risedronate. Take calcium at least 2 hours after risedronate.
- Antacids: Avoid antacids containing aluminum, magnesium, or calcium within 2 hours of risedronate, as they can interfere with absorption.
- NSAIDs: Concurrent use with nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of gastrointestinal irritation.
- Vitamin D: Ensure adequate vitamin D levels, as it enhances calcium absorption and supports bone health.
- Thyroid Hormones: Calcium can interfere with the absorption of thyroid medications. Take thyroid hormones at least 4 hours before or after calcium.
- Diuretics: Thiazide diuretics can increase calcium levels, while loop diuretics can decrease calcium levels. Monitor calcium levels closely.
- Iron Supplements: Iron can interfere with calcium absorption. Take iron supplements at least 2 hours apart from calcium.
- Risedronate: Typically 5 mg daily or 35 mg once weekly for osteoporosis. For Paget’s disease, 30 mg daily for 2 months.
- Calcium: 1,000-1,200 mg daily, depending on age and dietary intake. Take at least 2 hours apart from risedronate.
- Vitamin D: 600-800 IU daily to support calcium absorption.
- Administration: Take risedronate first thing in the morning on an empty stomach with water. Remain upright for 30 minutes.
- Duration: Long-term use may be required for osteoporosis management. Follow your healthcare provider’s instructions.
- Not Recommended: Risedronate is not typically used in children unless prescribed for specific conditions like osteogenesis imperfecta.
- Calcium: For children, calcium requirements vary by age. Follow pediatric guidelines for supplementation.
- Vitamin D: Ensure adequate vitamin D intake to support calcium absorption in children.
- Supervision: Use under strict medical supervision for pediatric patients with bone disorders.
- Mild to Moderate Impairment: No dose adjustment is needed for risedronate in patients with CrCl ≥30 mL/min.
- Severe Impairment: Avoid risedronate in patients with CrCl <30 mL/min.
- Calcium: Monitor calcium levels closely in renal impairment to avoid hypercalcemia or hypocalcemia.
- Hydration: Ensure adequate hydration to prevent kidney strain.
- Consultation: Consult a nephrologist for patients with advanced kidney disease.
Not available in a medicine form yet